Invited Lectures

NOTE: The opinions and data presented are the responsability of the authors. The Genetic Unit staff does not necessarily share their views. Please click on the article you are interested in.


  1. Therapeutic Approach with Growth Hormone.
    Franco Antoniazzi

  2. Rehabilitation and Functional Outcome in Osteogenesis Imperfecta.
    Jennifer Ault

  3. Clinical Databases For Osteogenesis Imperfecta.
    Nicholas J. Bishop

  4. Molecular Pathogenesis of Osteogenesis Imperfecta.
    Peter H. Byers

  5. Use And Limits Of Dual X-Ray Absorptiometry For Diagnosis And Follow-Up Of Patients With Osteogenesis Imperfecta.
    G. Chevrel

  6. Upper Extremity Problems In OI: Think Function Or Cosmesis.
    W.G. Cole

  7. Management Of A Molecular Database In OI.
    Raymond Dalgleish

  8. Lower Extremity Rodding In OI: What Is New?
    F. Fassier

  9. Generation Of A Knock-In Murine Model For Osteogenesis Imperfecta Reproducing The Biochemical, Molecular, Histological Characteristic Of Human Patients.
    Antonella Forlino and Joan C. Marini

  10. Disability Evaluation In Follow Up Of Osteogenesis Imperfecta.
    Paolo Fraschini

  11. Rehabilitation Of Children And Infants With Osteogenesis Imperfecta.
    Lynn H. Gerber

  12. Osteogenesis Imperfecta: Classification And Variants.
    Francis H. Glorieux, M.D., Ph.D.

  13. Transplantability And Therapeutic Effects Of Bone Marrow-Derived Mesenchymal Cells In Children With Severe Osteogenesis Imperfecta.
    Edwin M. Horwitz, Darwin J. Prockop, Lorraine A. Fitzpatrick, Winston, W.K. Koo, Patricia L. Gordon, Michael Neel, Michael Sussman, Paul Orchard, Jeffery C. Marx, Reed E. Pyeritz, Malcolm K. Brenner.

  14. Osteoblastic Activity in the OIM Mouse.
    I.Kalajzic., J.Terzic., K.Mack., D.Visnjic., A.Naprta., G.Gronowicz., S.H.Clark., D.Rowe

  15. Spinal Deformity In Osteogenesis Imperfecta.
    John P. Lubicky, M.D.

  16. Development Of Hammerhead Ribozymes As An Agent For Gene Therapy In Osteogenesis Imperfecta: Allele-Specific Suppression Of Mutant Type I Collagen mRNA.
    Joan C. Marini, Paul Dawson and Antonella Forlino

  17. Alendronate Trial In Adults With Osteogenesis Imperfecta (OI): Characteristics Of The Population At Baseline.
    P.J. Meunier, G. Chevrel, J.E. Charrin, E. Fontanges

  18. Neurologic Complications Of Osteogenesis Imperfecta.
    Gérard Mohr, M.D., FRCS(C), Martin BLACK, M.D., FRCS(C), Max AEBI, M.D, FRCS(C).

  19. Prenatal Diagnosis of Osteogenesis Imperfecta: Review of 183 Diagnostic Studies From 1985 to 1998.
    Melanie Pepin and Peter H. Byers

  20. Use Of Bisphosphonates For The Treatment Of Osteogenesis Imperfecta.
    Horacio Plotkin, M.D. and Francis H. Glorieux, M.D., Ph.D.

  21. Direct DNA Testing Of Collagen I Genes In Osteogenesis Imperfecta.
    Darwin J. Prockop, Jarmo Korkko, Maureen Kinnarney and Leena Ala-Kokko

  22. Orthopaedic treatment in OI.
    J.E.H.Pruijs

  23. Biochemical Markers Of Bone Metabolism In Children With Osteogenesis Imperfecta (OI).
    Frank Rauch, Rose Travers, Francis H. Glorieux

  24. Bone Histology And Histomorphometry In Osteogenesis Imperfecta (OI).
    Frank Rauch, Rose Travers, Francis H. Glorieux

  25. Steps in Developing a Strategy of Somatic Gene Therapy for Murine OI.
    D. Rowe, A. Lichtler, I. Kalajzic, D. Visjnic, J. Kalajzic, P. Liu and ML Stove

  26. Oral Findings In Osteogenesis Imperfecta.
    Stephane Schwartz

  27. Management Of Osteogenesis Imperfecta In Adolescents And Adults.
    David Sillence

  28. Can OI Result From Mutation In Genes Other Than Those For Type I Collagen?
    Michel van der Rest